Research Article
Does the Beck Cognitive Insight Scale Predict Response to Cognitive Remediation in Schizophrenia?
Table 2
Demographic and clinical variables.
| Patients who completed CRT () | |
| | M (SD) | Years of education | 11.65 (2.08) | Baseline antipsychotics total dose (mg/day in clz equivalents) | 615.38 (539.89) | Follow-up antipsychotics total dose (mg/day in clz equivalents) | 587.07 (414.45) | SAPS total, baseline | 25.26 (14.06) | SAPS total, follow-up | 19.05 (13.05) | SANS total, baseline | 26.42 (13.62) | SANS total, follow-up | 31.05 (12.95) | WASI FSIQ | 90.30 (11.89) | Global cognitive composite score (CSRB), baseline | −1.51 (1.10) | Global cognitive composite score (CSRB), follow-up | −1.36 (1.17) | BCIS total score, baseline | 2.70 (6.24) | BCIS total score, follow-up | 2.75 (4.98) | Diagnosis | (%) | Schizophrenia | 1 (5) | Schizophrenia, paranoid | 8 (40) | Schizoaffective disorder | 6 (30) | Schizophrenia, undifferentiated | 4 (20) | Psychosis NOS | 1 (5) |
|
|
; SAPS and SANS were not used for one patient. The difference in SAPS total score between baseline and follow-up is statistically significant (; ).
|